Skip to main content

ISCO

International Stem Cell CORP

Company with tickers: ISCO

CIK
1355790
Shares Outstanding
8,004,389

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Line Item Value
Revenue
Revenue (ASC 606) $2,315,000
Cost of Revenue $954,000
Gross Profit
Operating Expenses
Research & Development $156,000
Operating Income $-190,000
Net Income $-220,000
EPS (Basic) $-0.03
EPS (Diluted) $-0.03

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

By Segment (USD)

Component 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Biomedical Market $5,594,000 $5,936,000 $7,131,000 $6,866,000 $8,290,000 $8,502,000
Anti Aging Market $1,534,000 $1,240,000 $1,049,000 $923,000 $795,000 $598,000
Anti Aging Skincare Market $1,534,000 $1,240,000 $1,049,000 $923,000 $795,000 $598,000

By Geography (USD)

Component 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
United States $5,917,000 $7,016,000 $6,548,000 $7,727,000 $7,838,000
Asia $538,000 $806,000 $690,000 $726,000 $890,000 $719,000
Europe $290,000 $345,000 $393,000 $395,000 $407,000 $448,000
Other Regions $23,000 $108,000 $81,000 $120,000 $61,000 $95,000
North America $6,277,000